Arbutus Biopharma
ABUS
ABUS
49 hedge funds and large institutions have $73.1M invested in Arbutus Biopharma in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
11% less capital invested
Capital invested by funds: $81.7M → $73.1M (-$8.68M)
Holders
49
Holding in Top 10
–
Calls
$517K
Puts
$368K
Top Buyers
| 1 | +$3.8M | |
| 2 | +$888K | |
| 3 | +$825K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$815K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$476K |
Top Sellers
| 1 | -$5.73M | |
| 2 | -$1.68M | |
| 3 | -$1.2M | |
| 4 |
D.E. Shaw & Co
New York
|
-$660K |
| 5 |
TI
Telemetry Investments
New York
|
-$449K |